Crossmark

Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study

Published Online: 2020-12-18

Published Print: 2021-02

Authors

Ford, Janet H.

Stauffer, Virginia L.

McAllister, Peter

Akkala, Sreelatha

Sexson, Matthew

Ayer, David W.

Wang, Shufang
License Information

Text and Data Mining valid from 2020-12-18

Version of Record valid from 2020-12-18
More Information

Article History

First Online: 18 December 2020

Free to read: This content has been made available to all.

Document is current